{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T11:47:55Z","timestamp":1751456875126},"reference-count":68,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.vaccine.2009.11.081","type":"journal-article","created":{"date-parts":[[2009,12,15]],"date-time":"2009-12-15T09:32:01Z","timestamp":1260869521000},"page":"1838-1846","source":"Crossref","is-referenced-by-count":12,"title":["Enhancement of IL-10 bioactivity using an IL-10 peptide-based vaccine exacerbates Leishmania major infection and improves airway inflammation in mice"],"prefix":"10.1016","volume":"28","author":[{"given":"Gang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanbing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingdong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jude E.","family":"Uzonna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhikang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.11.081_bib1","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/ni1207-1281","article-title":"IL-10 or not IL-10: that is the question","volume":"8","author":"Jankovic","year":"2007","journal-title":"Nat Immunol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.11.081_bib2","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/ni1537","article-title":"Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10","volume":"8","author":"Stumhofer","year":"2007","journal-title":"Nat Immunol"},{"issue":"June","key":"10.1016\/j.vaccine.2009.11.081_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2008.00635.x","article-title":"Strategies for use of IL-10 or its antagonists in human disease","volume":"223","author":"O\u2019Garra","year":"2008","journal-title":"Immunol Rev"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.11.081_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1084\/jem.20070104","article-title":"Interleukin-10 production by effector T cells: Th1 cells show self control","volume":"204","author":"Trinchieri","year":"2007","journal-title":"J Exp Med"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2009.11.081_bib5","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1080\/02770900802207261","article-title":"IL-10, TGF-beta, IL-2, IL-12, and IFN-gamma cytokine gene polymorphisms in asthma","volume":"45","author":"Movahedi","year":"2008","journal-title":"J Asthma"},{"issue":"February (5)","key":"10.1016\/j.vaccine.2009.11.081_bib6","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1189\/jlb.0708448","article-title":"Endogenous suppression of mast cell development and survival by IL-4 and IL-10","volume":"85","author":"Speiran","year":"2009","journal-title":"J Leukoc Biol"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2009.11.081_bib7","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.4049\/jimmunol.180.5.2848","article-title":"IL-10 suppresses mast cell IgE receptor expression and signaling in vitro and in vivo","volume":"180","author":"Kennedy Norton","year":"2008","journal-title":"J Immunol"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2009.11.081_bib8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.166.2.1141","article-title":"The role of IL-10 in promoting disease progression in leishmaniasis","volume":"166","author":"Kane","year":"2001","journal-title":"J Immunol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.11.081_bib9","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/nm1106-1246","article-title":"Virus scores a perfect 10","volume":"12","author":"Klenerman","year":"2006","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.081_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12026-008-8016-2","article-title":"Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies","volume":"41","author":"Okwor","year":"2008","journal-title":"Immunol Res"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.11.081_bib11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nri2097","article-title":"T(H)1 cells control themselves by producing interleukin-10","volume":"7","author":"O\u2019Garra","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2009.11.081_bib12","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.4049\/jimmunol.162.3.1723","article-title":"A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells","volume":"162","author":"Groux","year":"1999","journal-title":"J Immunol"},{"issue":"December (6915)","key":"10.1016\/j.vaccine.2009.11.081_bib13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature01152","article-title":"CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity","volume":"420","author":"Belkaid","year":"2002","journal-title":"Nature"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.11.081_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1084\/jem.20061886","article-title":"CD4(+)CD25(\u2212)Foxp3(\u2212) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis","volume":"204","author":"Anderson","year":"2007","journal-title":"J Exp Med"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.11.081_bib15","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm1492","article-title":"Interleukin-10 determines viral clearance or persistence in vivo","volume":"12","author":"Brooks","year":"2006","journal-title":"Nat Med"},{"issue":"October (11)","key":"10.1016\/j.vaccine.2009.11.081_bib16","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1084\/jem.20061462","article-title":"Resolution of a chronic viral infection after interleukin-10 receptor blockade","volume":"203","author":"Ejrnaes","year":"2006","journal-title":"J Exp Med"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.11.081_bib17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1292\/jvms.62.583","article-title":"Effects of in vivo administration of anti-IL-10 or anti-IFN-gamma monoclonal antibody on the host defense mechanism against Plasmodium yoelii yoelii infection","volume":"62","author":"Kobayashi","year":"2000","journal-title":"J Vet Med Sci"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2009.11.081_bib18","first-page":"381","article-title":"Effects of in vivo administration of anti-IL-10 monoclonal antibody on the host defence mechanism against murine Salmonella infection","volume":"85","author":"Arai","year":"1995","journal-title":"Immunology"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.11.081_bib19","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/rheumatology\/keh083","article-title":"Effect of neutralizing antibodies to IL-10 and C5 on the renal damage caused by a pathogenic human anti-dsDNA antibody","volume":"43","author":"Ravirajan","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.vaccine.2009.11.081_bib20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1164\/rccm.200610-1405OC","article-title":"Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice","volume":"176","author":"Ma","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2009.11.081_bib21","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.4049\/jimmunol.179.8.5358","article-title":"Lymphotoxin alpha beta 2 (membrane lymphotoxin) is critically important for resistance to Leishmania major infection in mice","volume":"179","author":"Xu","year":"2007","journal-title":"J Immunol"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2009.11.081_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0022-1759(90)90458-8","article-title":"Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate","volume":"128","author":"Perosa","year":"1990","journal-title":"J Immunol Methods"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2009.11.081_bib23","doi-asserted-by":"crossref","first-page":"R1514","DOI":"10.1152\/ajpregu.00378.2003","article-title":"Interleukin-10 concentration determined by sandwich enzyme-linked immunosorbent assay is unrepresentative of bioactivity in murine blood","volume":"285","author":"Hillyer","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"September (8)","key":"10.1016\/j.vaccine.2009.11.081_bib24","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1177\/153537020623100818","article-title":"Elevated bioactivity of the tolerogenic cytokines, interleukin-10 and transforming growth factor-beta, in the blood of acutely malnourished weanling mice","volume":"231","author":"Hillyer","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.vaccine.2009.11.081_bib25","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1398-9995.2007.01384.x","article-title":"Novel cytokine peptide-based vaccines: an interleukin-4 vaccine suppresses airway allergic responses in mice","volume":"62","author":"Ma","year":"2007","journal-title":"Allergy"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.11.081_bib26","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jaci.2009.02.030","article-title":"Mechanisms and treatment of allergic disease in the big picture of regulatory T cells","volume":"123","author":"Akdis","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"August (5)","key":"10.1016\/j.vaccine.2009.11.081_bib27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2174\/156652408785160907","article-title":"Role of IL-10 in the resolution of airway inflammation","volume":"8","author":"Ogawa","year":"2008","journal-title":"Curr Mol Med"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.11.081_bib28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000076441","article-title":"Induction of TNF-alpha autoantibody production by AutoVac TNF106: a novel therapeutic approach for the treatment of allergic diseases","volume":"133","author":"Zuany-Amorim","year":"2004","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.081_bib29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1073\/pnas.97.2.767","article-title":"Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice","volume":"97","author":"Richard","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2009.11.081_bib30","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1073\/pnas.0611022104","article-title":"VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases","volume":"104","author":"Rad","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"August (23\u201324)","key":"10.1016\/j.vaccine.2009.11.081_bib31","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1016\/j.vaccine.2004.01.064","article-title":"Active immunization against murine TNFalpha peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection","volume":"22","author":"Capini","year":"2004","journal-title":"Vaccine"},{"issue":"April (15)","key":"10.1016\/j.vaccine.2009.11.081_bib32","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/S0264-410X(02)00732-6","article-title":"Synthetic IgE peptide vaccine for immunotherapy of allergy","volume":"21","author":"Wang","year":"2003","journal-title":"Vaccine"},{"issue":"August (25\u201326)","key":"10.1016\/j.vaccine.2009.11.081_bib33","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/S0264-410X(02)00266-9","article-title":"A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses","volume":"20","author":"Jegerlehner","year":"2002","journal-title":"Vaccine"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2009.11.081_bib34","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.4049\/jimmunol.178.11.7450","article-title":"A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosis","volume":"178","author":"Spohn","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.11.081_bib35","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.1016\/j.vaccine.2007.09.009","article-title":"A potential immunotherapy approach: mucosal immunization with an IL-13 peptide-based and virus-like particle vaccine in a mouse asthma model","volume":"25","author":"Ma","year":"2007","journal-title":"Vaccine"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.11.081_bib36","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1128\/IAI.72.11.6519-6527.2004","article-title":"Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes","volume":"72","author":"Nardin","year":"2004","journal-title":"Infect Immun"},{"issue":"December (26)","key":"10.1016\/j.vaccine.2009.11.081_bib37","doi-asserted-by":"crossref","first-page":"14648","DOI":"10.1073\/pnas.94.26.14648","article-title":"Role of B cells in antigen presentation of the hepatitis B core","volume":"94","author":"Milich","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2009.11.081_bib38","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.4049\/jimmunol.169.11.6120","article-title":"Determinants of autoantibody induction by conjugated papillomavirus virus-like particles","volume":"169","author":"Chackerian","year":"2002","journal-title":"J Immunol"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2009.11.081_bib39","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.4049\/jimmunol.154.10.5320","article-title":"IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis","volume":"154","author":"Scharton-Kersten","year":"1995","journal-title":"J Immunol"},{"issue":"December","key":"10.1016\/j.vaccine.2009.11.081_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-065X.1989.tb00557.x","article-title":"Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease","volume":"112","author":"Scott","year":"1989","journal-title":"Immunol Rev"},{"issue":"April (3)","key":"10.1016\/j.vaccine.2009.11.081_bib41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0014-4894(89)90120-3","article-title":"The role of TH1 and TH2 cells in experimental cutaneous leishmaniasis","volume":"68","author":"Scott","year":"1989","journal-title":"Exp Parasitol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.11.081_bib42","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.4049\/jimmunol.132.4.2072","article-title":"Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway","volume":"132","author":"Sacks","year":"1984","journal-title":"J Immunol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.11.081_bib43","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/intimm\/6.8.1117","article-title":"The Xid defect determines an improved clinical course of murine leishmaniasis in susceptible mice","volume":"6","author":"Hoerauf","year":"1994","journal-title":"Int Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.11.081_bib44","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1128\/IAI.73.4.2101-2108.2005","article-title":"Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesions","volume":"73","author":"Buxbaum","year":"2005","journal-title":"Infect Immun"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2009.11.081_bib45","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20041470","article-title":"A role for IgG immune complexes during infection with the intracellular pathogen Leishmania","volume":"201","author":"Miles","year":"2005","journal-title":"J Exp Med"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.11.081_bib46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1084\/jem.20052288","article-title":"Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity","volume":"203","author":"Woelbing","year":"2006","journal-title":"J Exp Med"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2009.11.081_bib47","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","article-title":"IL-10: the master regulator of immunity to infection","volume":"180","author":"Couper","year":"2008","journal-title":"J Immunol"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2009.11.081_bib48","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.4049\/jimmunol.181.10.7230","article-title":"Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthma","volume":"181","author":"Henry","year":"2008","journal-title":"J Immunol"},{"issue":"February (5)","key":"10.1016\/j.vaccine.2009.11.081_bib49","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1189\/jlb.1108698","article-title":"Defective IL-10 production in severe phenotypes of Crohn's disease","author":"Correa","year":"2009","journal-title":"J Leukoc Biol"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2009.11.081_bib50","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.4049\/jimmunol.181.3.2076","article-title":"IL-10 helps control pathogen load during high-level bacteremia","volume":"181","author":"Londono","year":"2008","journal-title":"J Immunol"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2009.11.081_bib51","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nm.1929","article-title":"Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10","volume":"15","author":"Sun","year":"2009","journal-title":"Nat Med"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2009.11.081_bib52","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIRCRESAHA.108.188243","article-title":"IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR","volume":"104","author":"Krishnamurthy","year":"2009","journal-title":"Circ Res"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.11.081_bib53","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.rmed.2008.09.020","article-title":"Inhaled IL-10 reduces biotrauma and mortality in a model of ventilator-induced lung injury","volume":"103","author":"Hoegl","year":"2009","journal-title":"Respir Med"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2009.11.081_bib54","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1517\/14712598.8.9.1309","article-title":"The role of IL-10 in preventing food-induced anaphylaxis","volume":"8","author":"Frossard","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2009.11.081_bib55","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1073\/pnas.79.12.3828","article-title":"Enhancing antibody: a novel component of the immune response","volume":"79","author":"Nemazee","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.11.081_bib56","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1210\/en.139.3.1278","article-title":"Regulation of insulin-like growth factor I (IGF-I) bioactivity in vivo: further characterization of an IGF-I-enhancing antibody","volume":"139","author":"Hill","year":"1998","journal-title":"Endocrinology"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.11.081_bib57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1677\/joe.0.1520123","article-title":"Actions of an IGF-I-enhancing antibody on IGF-I pharmacokinetics and tissue distribution: increased IGF-I bioavailability","volume":"152","author":"Hill","year":"1997","journal-title":"J Endocrinol"},{"issue":"August (1\u20132)","key":"10.1016\/j.vaccine.2009.11.081_bib58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1006989232646","article-title":"Binding and signalling properties of a growth hormone enhancing monoclonal antibody","volume":"198","author":"Beattie","year":"1999","journal-title":"Mol Cell Biochem"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.11.081_bib59","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1210\/me.8.8.1103","article-title":"Location of an epitope defined by an enhancing monoclonal antibody to growth hormone: some structural details and biological implications","volume":"8","author":"Beattie","year":"1994","journal-title":"Mol Endocrinol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.11.081_bib60","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1128\/IAI.01577-08","article-title":"Antibody-enhanced Fc gamma receptor-mediated endocytosis of Clostridium difficile toxin A","volume":"77","author":"He","year":"2009","journal-title":"Infect Immun"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2009.11.081_bib61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1677\/joe.0.1450169","article-title":"Epitope mapping and analysis of a growth-enhancing monoclonal antibody by limited tryptic digestion of porcine GH","volume":"145","author":"Shieh","year":"1995","journal-title":"J Endocrinol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2009.11.081_bib62","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1089\/aid.1994.10.1065","article-title":"Influence of deletions in N or C terminus of HIV-1 glycoprotein 120 on binding of infectivity-enhancing antibody","volume":"10","author":"Lee","year":"1994","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"December (24)","key":"10.1016\/j.vaccine.2009.11.081_bib63","doi-asserted-by":"crossref","first-page":"11518","DOI":"10.1073\/pnas.90.24.11518","article-title":"V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1","volume":"90","author":"Kliks","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.11.081_bib64","first-page":"297","article-title":"Enhancing antibody and its role in acquired immunodeficiency syndrome","volume":"158","author":"Robinson","year":"1993","journal-title":"West J Med"},{"issue":"July (14)","key":"10.1016\/j.vaccine.2009.11.081_bib65","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1073\/pnas.152147499","article-title":"Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1","volume":"99","author":"Jones","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.11.081_bib66","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/pro.5560051001","article-title":"Crystal structure of human interleukin-10 at 1.6 A resolution and a model of a complex with its soluble receptor","volume":"5","author":"Zdanov","year":"1996","journal-title":"Protein Sci"},{"issue":"December (26)","key":"10.1016\/j.vaccine.2009.11.081_bib67","doi-asserted-by":"crossref","first-page":"14620","DOI":"10.1073\/pnas.94.26.14620","article-title":"Identification of functional domains on human interleukin 10","volume":"94","author":"Gesser","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2009.11.081_bib68","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.4049\/jimmunol.148.11.3618","article-title":"Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes","volume":"148","author":"Kim","year":"1992","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0901888X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0901888X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T22:10:49Z","timestamp":1685225449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0901888X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0264410X0901888X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.11.081","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}